| 2025-11-10 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.5美元,归母净利润-4523.1万美元,同比去年增长-6640.83%
|
| 2025-11-10 |
财报披露：
美东时间 2025-11-10 盘前发布财报
|
| 2025-11-05 |
详情>>
股本变动：
变动后总股本1877.00万股
|
| 2025-08-11 |
详情>>
业绩披露：
2025年中报每股收益-0.94美元,归母净利润-1691万美元,同比去年增长-229.37%
|
| 2025-07-21 |
详情>>
内部人交易：
Cober Timothy股份减少187.00股
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益-0.77美元,归母净利润-1393.8万美元,同比去年增长-161.04%
|
| 2025-04-29 |
股东大会：
将于2025-06-10召开股东大会
会议内容 ▼▲
- 1.To elect three directors of the Company to hold office until the Annual Meeting to be held in 2028 or until their respective successors are duly qualified and elected;
2.To ratify the Audit Committee’s appointment of BDO USA, P.C., independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2025;
3.To cast an advisory vote on executive compensation;
4.To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2025-03-17 |
详情>>
业绩披露：
2024年年报每股收益-0.54美元,归母净利润-758.4万美元,同比去年增长70.94%
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.05美元,归母净利润-67.1万美元,同比去年增长93.40%
|
| 2024-08-12 |
详情>>
业绩披露：
2024年中报每股收益1.14美元,归母净利润1307.10万美元,同比去年增长61.65%
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益2.32美元,归母净利润2283.50万美元,同比去年增长15.53%
|
| 2024-04-26 |
股东大会：
将于2024-06-04召开股东大会
会议内容 ▼▲
- 1.To elect three directors of the Company to hold office until the Annual Meeting to be held in 2027 or until their respective successors are duly qualified and elected;
2.To ratify the Audit Committee’s appointment of RSM US LLP, independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2024;
3.To cast an advisory vote on executive compensation;
4.To approve an amendment to the Company’s 2019 Omnibus Stock and Incentive Plan, as amended (the “2019 Plan”), to increase the number of shares of common stock that the Company may issue under the 2019 Plan from 1,297,600 shares to 1,797,600 shares;
5.To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2024-03-27 |
详情>>
业绩披露：
2023年年报每股收益-3.85美元,归母净利润-2609.9万美元,同比去年增长55.74%
|
| 2024-02-20 |
股东大会：
将于2024-03-21召开股东大会
会议内容 ▼▲
- 1.An amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 15,000,000 shares to 30,000,000 shares;
2.The adjournment of the Special Meeting to solicit additional proxies if there are insufficient proxies at the Special Meeting to approve the foregoing proposal.
|
| 2024-02-08 |
复牌提示：
2024-02-08 10:35:09 停牌，复牌日期 2024-02-08 10:40:20
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.54美元,归母净利润-1017.1万美元,同比去年增长75.33%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益1.27美元,归母净利润808.60万美元,同比去年增长130.68%
|
| 2023-04-28 |
股东大会：
将于2023-06-15召开股东大会
会议内容 ▼▲
- 1.To elect three directors of the Company to hold office until the Annual Meeting to be held in 2026 or until their respective successors are duly qualified and elected.
2.To ratify the Audit Committee’s appointment of RSM US LLP, independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2023.
3.To cast an advisory vote on executive compensation.
4.To cast an advisory vote on the frequency of an advisory vote on executive compensation.
5.To approve an amendment to the Company’s 2019 Omnibus Stock and Incentive Plan, as amended (the “2019 Plan”), to (i) increase the number of shares of common stock that the Company may issue under the 2019 Plan from 797,600 shares to 1,297,600 shares; and (ii) remove the limitation on the maximum number of shares of common stock with respect to which awards may be granted to any one participant during any calendar year.
6.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to allow the Company to exculpate certain officers from liability for breach of the duty of care in certain actions, subject to certain exceptions, in accordance with recent changes to the Delaware General Corporation Law.
7.To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2022-04-29 |
股东大会：
将于2022-06-09召开股东大会
会议内容 ▼▲
- 1.To elect three directors of the Company to hold office until the Annual Meeting to be held in 2025 or until their respective successors are duly qualified and elected;
2.To ratify the Audit Committee’s appointment of RSM US LLP, independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2022;
3. To cast an advisory vote on executive compensation;
4.To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2021-12-22 |
股东大会：
将于2022-01-27召开股东大会
会议内容 ▼▲
- 1.To elect three directors of the Company to hold office until the Annual Meeting to be held in 2024 or until their respective successors are duly qualified and elected;
2.To ratify the Audit Committee’s appointment of Ernst & Young LLP, independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2021;
3.To cast an advisory vote on executive compensation;
4.To approve an amendment to the Company’s 2019 Omnibus Stock and Incentive Plan, as amended, to increase the limitation on the maximum number of shares of the Company’s common stock with respect to which awards may be granted to any one participant during any calendar year to 125,000 shares of common stock;
5.To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2021-10-04 |
股东大会：
将于2021-10-22召开股东大会
会议内容 ▼▲
- 1.the issuance of (i) up to 66,250 shares of Series A Preferred Stock, up to 3,508,306 shares of Common Stock and 1,031,250 Warrants to Conversant in connection with the Private Placement, the Warrant Issuance, the Backstop Issuance and the Equity Accordion (each as defined in the accompanying Amendment to the Original Proxy Statement), which Series A Preferred Stock and Warrants will be convertible into or exercisable for Common Stock, subject to the terms set forth in the Certificate of Designations and Warrant Agreement, respectively;
2.an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 4,333,334 shares to 15,000,000 shares;
3.an amendment to the Company’s 2019 Omnibus Stock and Incentive Plan (the “2019 Plan”) to increase the number of shares of Common Stock that the Company may issue under the 2019 Plan from 150,000 shares to 797,699 shares and to exclude 257,000 shares from the minimum vesting provisions of the 2019 Plan;
4.the issuance to Arbiter of up to 183,959 shares of Common Stock in connection with the Backstop Issuance;
5.the adjournment of the Special Meeting to solicit additional proxies if there are insufficient proxies at the Special Meeting to approve the foregoing proposals.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-31 |
股东大会：
将于2021-10-12召开股东大会
会议内容 ▼▲
- 1.the issuance of up to 150,000 shares of Series A Preferred Stock to Conversant, which shares will be convertible into shares of our Common Stock;
2.an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 4,333,334 shares to 15,000,000 shares;
3.an amendment to the Company’s 2019 Omnibus Stock and Incentive Plan to (i) increase the number of shares of Common Stock that the Company may issue under such plan from 150,000 shares to 797,699 shares and (ii) exclude 257,000 shares from the minimum vesting provisions of such plan;
4.the adjournment of the Special Meeting to solicit additional proxies if there are insufficient proxies at the Special Meeting to approve the foregoing proposals.
|
| 2020-12-14 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2020-11-03 |
股东大会：
将于2020-12-09召开股东大会
会议内容 ▼▲
- 1.To elect three directors of the Company to hold office until the Annual Meeting to be held in 2023 or until their respective successors are duly qualified and elected;
2.To ratify the Audit Committee’s appointment of Ernst & Young LLP, independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2020;
3.To cast an advisory vote on executive compensation;
4.To approve amendments to the Company’s Certificate of Incorporation to declassify the Company’s Board of Directors;
5.To approve amendments to the Company’s Certificate of Incorporation to effect, at the discretion of the Company’s Board of Directors, (i) a reverse stock split of our common stock at one of the following ratios: 1-for-10, 1-for-15 or 1-for-20, with the ultimate ratio to be determined by the Company’s Board of Directors in its sole discretion; and (ii) a reduction of the number of authorized shares of our common stock in a corresponding proportion, subject to rounding up to the next whole number of shares;
6.To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2019-04-08 |
股东大会：
将于2019-05-14召开股东大会
会议内容 ▼▲
- 1.To elect three directors of the Company to hold office until the Annual Meeting to be held in 2022 or until their respective successors are duly qualified and elected;
2.To ratify the Audit Committee’s appointment of Ernst & Young LLP, independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2019;
3.To cast an advisory vote on executive compensation;
4.To approve the Company’s 2019 Omnibus Stock and Incentive Plan;
5.To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2018-04-06 |
股东大会：
将于2018-05-10召开股东大会
会议内容 ▼▲
- 1. To elect four directors of the Company to hold office until the Annual Meeting to be held in 2021 or until their respective successors are duly qualified and elected;
2. To ratify the Audit Committee’s appointment of Ernst & Young LLP, independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2018;
3. To cast an advisory vote on executive compensation;
4. To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2017-04-14 |
股东大会：
将于2017-05-16召开股东大会
会议内容 ▼▲
- 1. To elect three directors of the Company to hold office until the Annual Meeting to be held in 2020 or until their respective successors are duly qualified and elected;
2. To ratify the Audit Committee’s appointment of Ernst & Young LLP, independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2017;
3. To cast an advisory vote on executive compensation;
4. To cast an advisory vote on the frequency of an advisory vote on executive compensation;
5. To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|
| 2016-04-15 |
股东大会：
将于2016-05-19召开股东大会
会议内容 ▼▲
- 1. To elect three directors of the Company to hold office until the Annual Meeting to be held in 2019 or until their respective successors are duly qualified and elected;
2. To ratify the Audit Committee’s appointment of Ernst & Young LLP, independent accountants, as the Company’s independent auditors for the fiscal year ending December 31, 2016;
3. To cast an advisory vote on executive compensation;
4. To transact any and all other business that may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.
|